Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma

Saved in:
Bibliographic Details
Published inBlood Vol. 137; no. 8; pp. 1124 - 1129
Main Authors Strati, Paolo, Jain, Preetesh, Johnson, Ralph J., Forbes, Sheryl, Feng, Lei, Samaniego, Felipe, Rodriguez, Maria A., Fayad, Luis E., Hagemeister, Fredrick, Westin, Jason, Wang, Michael, Neelapu, Sattva S., Nastoupil, Loretta J., Fowler, Nathan H.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 25.02.2021
American Society of Hematology
Subjects
Adult
Antineoplastic Agents - therapeutic use
Female
Follow-Up Studies
Humans
Lenalidomide - therapeutic use
Letter to
Lymphoma, Follicular - drug therapy
Male
Middle Aged
Rituximab - therapeutic use
Survival Analysis
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Feature-2
ObjectType-Correspondence-1
ObjectType-Article-3
L.J.N. and N.H.F. contributed equally to this work.
P.S. and P.J. contributed equally to this work.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.2020007994